Abstract-The increasing complexity of software in implantable medical devices such as cardiac pacemakers and defibrillators accounts for over 40% of device recalls. Testing remains the principal means of verification in the medical device certification regime. Traditional software test generation techniques, where the tests are generated independently of the operational environment, are not effective as the device must be tested within the context of the patient's condition and the current state of the heart. It is necessary for the testing system to observe the system state and conditionally generate the next input to advance the purpose of the test. To this effect, a set of general and patient condition-specific temporal requirements is specified for the closed-loop heart and pacemaker system. Based on these requirements, we describe a closed-loop testing environment between a timed automatabased heart model and a pacemaker. This allows for interactive and physiologically relevant model-based test generation for basic pacemaker device operations such as maintaining the heart rate and atrial-ventricle synchrony. We also demonstrate the flexibility and efficacy of the testing environment for more complex common timing anomalies such as reentry circuits, pacemaker mode switch operation and pacemaker-mediated tachycardia. This system is a step toward a testing approach for medical cyber-physical systems with the patient-in-the-loop.
I. INTRODUCTION
Safety recalls of pacemakers and implantable cardioverter defibrillators due to firmware problems between 1990 and 2000 affected over 200,000 devices. This encompasses 41% of the devices recalled [1] . An estimated 1.3 million device checks and analyses and 36,187 device replacements resulted from the advisories at a cost of approximately $870 million. In 1996, 10% of medical devices recalls were caused by software-related issues. In June of 2006, software errors in medical devices made up 21% of recalls. During the first half of 2010, the Food and Drug Administration (FDA) issued 23 recalls of defective devices, all of which are categorized as Class I, meaning there is "reasonable probability that use of these products will cause serious adverse health consequences or death." At least six of the recalls were likely caused by software defects [2] , [3] .
The FDA currently does not request or review the medical device software during pre-market submission. While no specific requirements or software verification standards are issued, a set of general guidelines for software evaluation are recommended [4] , [5] , [6] . The responsibility to demonstrate the safety and efficacy of the device software is solely on the manufacturer. This is currently satisfied by the documentation of code inspections, static analysis, module-level testing and integration testing and their purpose is to establish "reasonable assurance of safety and effectiveness". These tests however fail to check for the correctness of the software and are largely open-loop tests that do not consider the context of the patient. Software is reviewed by the FDA only in the incident of a device recall. Software-related recalls are often issued in the form of Safety Alerts by the Food and Drug Administration (FDA) such as "Safety alert -Pacemaker may revert to VVI mode at 70 beats/min if programmed to one of several specific ventricular pulse widths" [2] .
An effective software verification methodology is therefore needed for the risk analysis and certification of medical device software during the pre-market submission phase. Testing for medical device software currently is ad hoc, error prone, and very expensive. Traditional methods of testing do not suffice as the test generation cannot be done independently of the current state of the patient and organ. As the testing environment (i.e., patient condition) is not entirely under the control of the tester, the problem changes significantly as a degree of nondeterminism is introduced in the process. Implantable medical devices are a primary example of Medical Cyber-Physical Systems where the safety and efficacy of the device and device software must be evaluated within a closed-loop context of the patient. The key challenge is in the generation of physiologically relevant tests such that the device does not provide inappropriate therapy and does not adversely affect the safety of the patient. In addition, test generation must be interactive and adaptive such that the previous test stimulus affects the current state of the patient. The test generator must consider the current state when generating the next input in a way that advances the purpose of the test. The problem, therefore, becomes one of controller synthesis and cannot be addressed by an off-theshelf model checker [7] .
The focus of this effort is three-fold: (a) We provide a set of general and patient condition-specific pacemaker software requirements to ensure the safety of the patient, (b) We developed a timed automata-based heart model and pacemaker device model for interactive and clinically relevant test generation, and (c) We test the closed-loop system over a variety of basic operation tests where the heart rate must be maintained and the atrial-ventricle synchrony must be maintained. Furthermore, we present a set of complex, but common, cases such as supraventricular tachycardia due to timing derangements caused by reentry circuits, pacemaker mode-switch operation and pacemaker mediated tachycardia condition. With this approach of model-based testing, an executable functional model of the pacemaker is created at an early stage in the development process. The focus of our safety analysis is primarily on the timing behavior of the closed-loop system as heart is the most important natural real-time system. The timing of the intrinsic or induced pacing directly affects the hemodynamics of the heart and is a primary function of the stroke volume.
A. Model-based Medical Device Testing
Software embedded in a pacemaker or implantable defibrillator may have more than 80,000 lines of code [8] . There is currently no software testing standard for implantable medical devices. Testing is the observation of a program in execution under controlled conditions. The outcome of a test is compared with an oracle to determine the appropriateness or correctness of the therapy. While formal methods of verification is needed for medical device software [9] , [10] , [11] , testing continues to be required because it can expose different kinds of problems (e.g., compiler bugs), can examine the program in its system context, and increases the diversity of evidence available. We do not have access to the source code and black-box testing limits the scope of evaluation. It is therefore necessary to develop a framework for model-based testing wherein the device itself, or a model of the device, is tested in closed-loop with the model of the patient or the organ of concern. The key challenge with model-based testing is having a good test generator. In the case for implantable medical devices, the challenges for software testing and test generation are manyfold:
1. Testing must be physiologically relevant Testing cannot be expected to catch every error in the program and it is impossible to evaluate every execution path. Many software errors, like unintended restarts or incorrect measurements, do not surface until after the devices are approved and in use. It is therefore necessary to provide the appropriate kind and level of abstraction of the patient and device model for testing. In our previous work [12] , we developed a Virtual Heart Model (VHM) and dual chamber DDD pacemaker model in Simulink for medical device validation. The VHM is an electrophysiological model of the heart and models the timing and electrical conduction of the heart with both intrinsic and artificial pacing signals. In this paper, we use the VHM for closed-loop testing of pacemaker functionality for baseline and common complex test cases.
2. Non-deterministic factors in testing Traditional software testing is an open loop exercise to test for generic bugs and incorrect execution given a set of structural coverage criteria. This lends itself to Automated Test Generation by methods such as theorem proving, constraint logic programming and symbolic execution, model checking, using an event-flow model and using a Markov chains model [7] . The test-generation problem becomes significantly more complex and difficult when the program under test is non-deterministic or when the functionality of the program is a function of not only the computing and communication components but the operational environment. In the case of an implantable medical device such as an artificial pacemaker, the closed-loop system of the heart and the device must be tested as a whole, within the context of the patient's condition (see Fig. 1 ).
3. Interactive and adaptive testing The primary approach to system-level testing of medical devices is unit testing using a playback of pre-recorded Heart & PM response changes the demand Current effort Figure 1 . Closed-loop model of the heart and pacemaker in the context of the patient condition. Our focus is on the inner loop of the heart model and the pacemaker model.
electrogram and electrocardiogram signals [13] , [14] . This tests if the input signal triggers a particular response by the pacemaker but has no means to evaluate if the response was appropriate for the patient condition. Furthermore, this approach of "tape testing" is unable to check for safety violations due to inappropriate stimulus by the pacemaker. Pacemaker Mediated Tachycardia (PMT), a condition that is described later in this paper, is a strong example of why we need an interactive and adaptive test generation systems such as the VHM. PMT is a condition where the pacemaker inappropriately drives the intrinsic heart-rate toward the upper rate limit. With a tape test, PMT would not occur and the response of the pacemaker could be classified as appropriate therapy.
The focus of this work is on the development of a system and methods for integration and system-level testing for implantable cardiac pacemakers. To address this, we specify a set of general and condition-specific requirements for the closed-loop system. We evaluate this by constructing a set of monitors to test for timing and safety conditions for each case.
B. . Organization
The rest of this paper is organized as follows. In Section II, we describe the construction and interfaces of a timed automata based heart model developed in Simulink. Section III presents the model of a pacemaker which interfaces with the heart model to generate a set of closed-loop physiological tests cases described in Section IV. Sections V and VI present the set of closed-loop system requirements along with test generation and testing of the closed-loop system with a set of monitors. We then conclude the paper with a set of future directions toward more rigorous and formal medical system verification.
II. HEART MODEL We developed a timed automata-based Virtual Heart Model (VHM) to model the timing and electrical conduction properties of the heart. The model, designed in Simulink, was constructed to serve as an adaptive test generator for a variety of heart conditions. The VHM responds to both intrinsic (natural) pacing and external (artificial) pacing stimulus and is capable of generating tests for the following common conditions: 1) Normal Sinus Rhythm and Sinus Bradycardia 2) Wenckebach Second-degree Heart Block 3) Atrial Flutter 4) Pacemaker Mediated Tachycardia In our previous work [12] , both the normal and malfunctioning heart and pacemaker conditions were compared to the text book case studies of real patients and were confirmed by the electrophysiologist to be clinically relevant. The parameter ranges used in this effort are standard ranges used in practice. Functional validation of output electrogram signals by the medical expert provides the necessary confidence in the modeling effort. For completeness, we briefly describe the design of the VHM using timed automata. For more details, refer to [12] .
A. . Timing Model of the Virtual Heart Model
Modeling individual cells in order to obtain a view of the entire heart is processor heavy and contains extraneous information for purposes of device testing. Instead, the VHM utilizes the timing properties of the heart to obtain a macrolevel view by lumping cells into node and path automaton.
The heart can be represented as a conduction network (Fig. II-A) , because a section of activated heart tissue can only activate its neighboring tissue. For example, a conduction path from tissue A to tissue B, a stimulus cannot reach B if A is in refractory (i.e. the cells are discharged), even if B is at rest. We can use this idea to model a section of tissue as two node automata connected by one path automaton. The refractory properties of the component are represented by the nodes and the conduction properties between the nodes are modeled by the path. We can represent different structures of the heart using nodes and paths with different parameters. The basic state transitions of the node automaton and the path automaton are shown in Fig. 2(b) and Fig. 2(c) . In node automaton, the refractoriness is modeled as the Effective Refractory Period (ERP) when no conduction can occur, Relative Refractory Period (RRP) when attenuated conduction may occur and Rest states when the cell is fully excitable. In path automaton, the tissue conduction properties are modeled as no conduction (Idle), antegrade or forward conduction (Ante), retrograde or backward conduction (Retro), conduction in both directions (Double), and conflict (Conflict) state. Each state has an internal timer T state , and the paths have conduction velocity V state . The default refractory and conduction parameters are tuned in relation to the true refractory periods measured in clinical electrophysiology studies [15] . These allow us to produce clinically-relevant results [12] . It has been studied in [16] and [17] that the action potential duration is dependent on the timing of stimulus (see Fig. 2(a) ). We use an exponential approximation of the trend to create similar behavior. In addition, the portion of the total refractory period that is unexcitable is dependent on the amplitude of the stimuli [18] . For simplification, we assume a fixed amplitude for all stimuli, which is the case in most implantable devices. The state transitions of node automaton and path automaton are shown below (all timer equations are described in [12] ):
Node automata state transitions -When activation signal is received at a node
• In Rest state: go to ERP state, calculate the value of timer T erp , reset the ERP timer, activate neighboring paths and change the T ante or T retro timers.
• In ERP state: calculate T erp , neighboring paths are not activated.
• In RRP state: go to ERP state, activate neighboring paths, calculate T erp , and change the conduction velocity of neighboring paths.
-When no activation signal is received at node
• In Rest state: SA and AV nodes count down the Rest timer, when the timer times out, activate itself, go to ERP state, activate neighboring paths and change the conduction speed of neighboring paths. Other nodes stay in Rest state.
• In ERP state: count down ERP timer and go to RRP state after the timer runs out.
• In RRP state: count down RRP timer and go to Rest state after the timer runs out.
Path automata state transitions:
The path automata is initially Idle until either of the nodes it connects to is activated (Act 1 or Act 2). The path starts the antegrade or retrograde conduction timer according to which node is activated. After T ante or T retro times out, the path activates the node at the opposite end. Because this node activates all paths it is connected to, the path where the activation originated goes to Conflict state to prevent back conduction. If a path is already in antegrade conduction when a second activation signal enters from the opposite end, the path enters the Double state. Both T ante and T retro count down until the timers correspond to the same location in space and the path goes to the Conflict state then back to Rest state.
B. . Functional and Formal VHM interface
Our platform provides two interfaces, a formal signal for interfacing with medical device software and a functional electrogram for real device implementation. We introduce probes into the model which mimic sensing from electrodes in catheters or pacemaker leads. The probes are placed in specific areas to capture key activation timing intervals in the heart. These probes generate synthetic unipolar electrograms by multiplying activations on neighboring paths by a distance-dependent Gaussian factor and summing them together. The bipolar electrograms are calculated as the differences between two unipolar signals. The bipolar formal signal is generated using an AN D operation between the two unipolar formal signals. Varying the location of the probe pair and the conduction delay of the path can causes changes in electrogram morphology. The formal signal is useful for interacting with medical device software running at a lower frequency than the VHM.
C. . Simulink Implementation of the VHM
The general automata and probe set used in our simulations is shown in Fig. 3(b) with 32 nodes and 33 paths. A simulation GUI developed in Simulink and the automata network is superimposed on the heart anatomy. The length of paths are measured in pixels to provide a relative length relationship between different heart structures. Users can track the updated values of timers on the right side tables. Users can view electrograms and deliver programmed pacing in real-time. Simulink was chosen because both the functional and formal models could be developed from a common kernel. The VHM interfaces with the pacemaker model, which is described next.
III. PACEMAKER MODEL

A. . Pacemaker model
As no pacemaker software or model is available, we developed models of the AAI and DDD pacemaker modes to mimic the behavior of a real pacemaker based on pacemaker timing cycles. AAI mode is a single chamber mode which senses and paces in the atrium. Its function is to keep the atrial rate above a certain threshold. DDD mode is a dual chamber mode which senses and paces in both atrium and ventricle. Besides maintaining both atrial and ventricular rate, DDD mode also includes Atrial-Ventricular (A-V) synchrony, which can optimize hemodynamics. The 5 basic timing cycles for a DDD mode pacemaker are shown in Fig. 4 [19] . Since these timing cycles are mostly independent of each other, we model them as 5 independent modules running in parallel. This also enable us to use the same model for different pacemaker modes by disabling the corresponding module. The description and design of the 5 timer modules are introduced below:
1. Lowest Rate Interval (LRI): LRI is the most basic timing cycle for pacemaker. Its function is to maintain the heart rate above a certain level. It can be modeled as a timer with some logic. The timer is started and reset by ventricular event. If no ventricular event is sensed before the timer runs out, the pacemaker will deliver ventricular pacing.
2. Atrio-Ventricular Interval (AVI): The function of the AVI module is to keep A-V synchrony. The timer is started by atrial events. If no ventricular event happens before the timer runs out, the pacemaker will deliver ventricular pacing.
3. Three auxiliary modules: The post ventricular atrial refractory period (PVARP) module is a blocking period which is started by a ventricular event. During this period no atrial sense event can be triggered. The ventricular refractory period (VRP) module is a blocking interval which is started by a ventricular event. During this period no ventricular sense event can be triggered. These two modules are designed to filter out noise so that only real events are sensed. The upper rate interval (URI) component provides an upper bound for ventricular pacing. AVI timer is extended and the ventricular pacing is withheld to prevent the pacemaker from pacing the ventricle too fast.
Besides the basic timing cycles, a simplified version of Mode-switch operation was implemented. With Mode-swtich, the pacemaker should switch from DDD to VDI mode if the atrial rate is above certain threshold and switch from VDI to DDD mode if the atrial rate drops below a certain level. This function is to ensure the A-V synchrony function of the pacemaker does not track abnormally fast atrial rates and cause ventricular tachycardia. A timer is set to monitor the interval between two consecutive atrial events. Any value smaller than a specified threshold is considered as a fast atrial beat. A counter tracks the number of fast atrial beats. If there are certain number of consecutive fast atrial beats the pacemaker will switch from DDD to VDI. During VDI mode the pacemaker paces and senses the ventricle but still keeps track of the interval between atrial beats. If a slow atrial beats is detected, the pacemaker will switch from VDI to DDD mode.
IV. PHYSIOLOGICAL CASE STUDIES
We simulated four common clinically-relevant heart conditions using the closed-loop VHM and pacemaker model. These cover the basic functionality of the pacemaker within a closed-loop context. Based on these conditions we derived a set of safety and efficacy requirements for the pacemaker (Section V). Following this, we applied monitors to the closeloop system to evaluate if the requirements are satisfied (Section VI). This section describes the electrophysiological details of each case so that we may understand the clinical relevance prior to testing. The detailed cases and detailed description can be found in [12] .
A. Maintain appropriate heart rate
Maintaining appropriate heart rate is essential for keeping efficient blood flow throughout the body. Heart rate can be classified into Normal Sinus Rhythm (NSR, i.e. normal heart rate), Bradycardia (i.e. abnormally slow heart rate) and Tachycardia (i.e. abnormally fast heart rate). The mechanism of Sinus Bradycardia is when the SA node, which serves as natural pacemaker, fails to generate a fast enough heart rate to satisfy blood demand of the body. Sinus Bradycardia is the most basic and common arrhythmia which requires pacemaker therapy. The pacemaker can provide electrical impulses at the appropriate time intervals to maintain the heart rate above certain level. Pacemaker does not provide Tachycardia therapy but it needs to prevent itself from inducing the heart into the dangerous Tachycardia condition.
B. Maintain Atrioventricular Synchrony
Besides heart rate, atrioventricular (AV) synchrony is an important property to be satisfied to maintain efficient hemodynamics. AV heart block is a heart condition where the electrical conduction between the atria and ventricles is delayed or blocked. This is caused by the abnormal behavior of the AV node. In this case, we introduce the Wenchebach-type AV block, which features a progressively prolonged AV delay that eventually results in dropped beats. Fig. 5 shows the electrograms, the corresponding ERP period and conduction delay of the AV node automata in a VHM simulation.
From the His Bundle Electrogram (HBE in the figure), we observe the second stimulus which arrived at the AV node (marked as A in the figure) falls into the RRP period of the AV node. Consequently, the ERP period and the conduction delay of AV node are increased according to the timer equations referenced in Section II. After a series of stimuli, the ERP period is longer than the interval between two stimuli. This results in the blocking of the last stimulus at the AV node, causing a dropped beat (marker 1 in the figure). In the AV heart block situation, a dual chamber pacemaker should be employed to maintain the AV synchrony by appropriately pacing the atrium and ventricle in a coordinated manner.
C. Pacemaker Mediated Tachycardia
Pacemaker Mediated Tachycardia (PMT) is the circumstance where the pacemaker paces the heart at an inappropriately high rate. In the following two cases, we observe the pacemaker can introduce complications that may lead to unsafe heart conditions.
1) Endless Loop Tachycardia (ELT):
is a situation where the pacemaker and heart tissue form a "circuit", which is known as reentry circuit. Reentry circuit is one of the most common reason for Tachy-arrhythmia. Its mechanism is based on timing anomalies caused by additional (accessory) conduction pathways within the heart. In this situation the "additional pathway" is the pacemaker AV synchrony function. Fig. 6 illustrates the mechanism of a reentry circuit.
A reentry circuit is formed by two conduction pathways. One has a short conduction delay but with a long blocking period (ERP), and the other has long conduction delay but with a short blocking period. During normal conduction (Fig. 6-0) , stimulus propagates though both pathways. Since the signal through the fast pathway arrives at the circuit exit earlier, it will conflict with the signal through the slow pathway and they cancel each other. In this case, the circuit is equivalent to a single fast pathway. However, if another stimulus enters into the circuit shortly after the previous one (Fig. 6-1 ), it will be blocked in the fast pathway and go through the slow pathway as the fast pathway has a longer blocking period. When this stimulus arrives the circuit exit ( Fig. 6-2) , the blocking period of the fast pathway whould have ended and the stimulus propagates retrogradely (i.e. in reverse direction to normal conduction) through the fast pathway. The stimulus will then loop around the circuit and send stimuli to both the circuit's entry and exit (Fig. 6-3 ). Since the timing interval of circling around the circuit is shorter than the intrinsic heart rate, the circuit will become the dominating source of activation for the heart and cause Tachycardia. This condition The first ventricle sense (VS) is a Premature Ventricular Contraction (PVC). It propagates retrogradely to the atrium and triggers atrial sense (AS). The AS-VP interval is equal to the AVI timer value of the pacemaker. The VP-AS intervals are equal to the first VS-AS interval, indicating all VPs are also going retrogradely to the atrium. The resulting heart rate is around 150bpm. must be detected by the pacemaker and must inhabit pacing that may lead to assisting the Tachycardia condition. Fig. 7 shows the mechanism of ELT where natural conduction pathway serves as the slow pathway of the circuit and the A-V synchrony function of the pacemaker serves as the fast "pathway". A Premature Ventricle Contraction (PVC) can trigger retrograde conduction through the slow pathway and triggers atrial sense event in the pacemaker. The pacemaker will then pace the ventricle after the AVI timer runs out, triggering another retrograde conduction and causing reentrant tachycardia. The VHM's simulation result is shown in Fig. 8 .
2) Atrial Flutter and Pacemaker Mode-Switch function: Supraventricular Tachycardia (SVT) is the most common
Tachy-arrhythmia and features a very fast atrial rate. SVT itself is not fatal since a functioning AV node will filter out some of the stimuli to the ventricle and the ventricular rate remains relatively normal. However, complications may arise if there exist other means, besides the AV node, to provide A-V synchrony. This is likely in the form of additional pathways or due to fast atrial "tracking" by a DDD dual chamber pacemaker. Tracking is said to occur when the pacemaker attempts to maintain A-V synchrony by following the atrial signal with a ventricular pace, even when the atrial rate is above normal.
Atrial Flutter is one of the most common SVTs and is caused by reentry circuits. In a large population group, there exists a slow conduction pathway in the right atrium which forms a reentry circuit along with the normal conduction pathway. Fig. 9 -a shows synthetic EGMs of an intermittent Atrial flutter case without pacemaker. During Atrial flutter, the atrial rate is around 240bpm but only around half of them conduct to the ventricle so the ventricular rate is around 100bpm. When the Atrial flutter terminates, the heart condition changes to bradycardia.
With a dual chamber pacemaker in DDD mode implanted, the heart rate and A-V synchrony are maintained during Bradycardia. However, during Atrial flutter, the A-V synchrony function of the pacemaker will pace the ventricle for every sensed atrial event and lead to unsafe ventricular tachycardia. (Fig. 9-b ) During SVT-like Atrial Flutter, maintaining an appropriate ventricular rate is much more important than maintaining A-V synchrony. In order to prevent inappropriate A-V synchrony, the pacemaker should be able to detect SVT and disable the A-V synchrony function during SVT while After detecting five consecutive fast atrial events, the pacemaker switchs from DDD mode to VDI mode (first MS marker in Fig. 9-c) , which is a single chamber mode that paces and senses only in the ventricle while monitoring the interval between atrial events. After the SVT terminates, the pacemaker detects a long coupling interval between atrial events and switches back to DDD mode (second MS marker in Fig. 9-c) . With the Mode Switch function, the pacemaker delivers appropriate therapy during different heart conditions. A more detailed description can be found in [20] .
V. CLOSED-LOOP REQUIREMENTS
In this section, we describe a set of requirements that are imposed on the closed-loop system to guarantee the safety and efficacy of the system. These requirements can not only be used for testing methods proposed here, but also for verification of the closed-loop system. While these requirements are a general set of requirements, our testing is only applicable to this select set and is currently not generalizable to other requirements or other device types.
A. Patient condition
From a physiological point of view there are certain requirements that the closed-loop system needs to satisfy. Some properties are absolute and some of them are conditional. For conditional properties, we specify heart states as patient conditions (see Fig. 10 ). In the closed-loop system these heart states are connected to the heart model parameters and won't Brady Intrinsic heart rate<60bpm Trest_SA>1000
Sinus Tachy
Intrinsic heart rate>120bpm Trest_SA<500
A-V Block AV node ERP is long so that A-V conduction is slow or blocked TERP_AV>400 SVT Atrial rate above 200 due to reentry circuit
Interval between two Activation_SA is shorter than 250ms && Trest_SA>600 Figure 10 . Patient state and equivalence in VHM be changed by the pacemaker therapy. This will allow us to evaluate whether the pacemaker provides an appropriate therapy for certain types of arrhythmias. Fig. 11 shows several general requirements that a rhythmmanagement implantable device should be able to satisfy, as well as the corresponding VHM logic. The requirements range from safety requirements to efficacy requirements and each requirement is assigned a priority. The device should always try to satisfy a higher priority requirement even if a lower priority requirement may be violated, and it should not try to satisfy a lower priority requirement if a higher priority requirement may be violated. The highest priority requirements have the smallest priority value.
B. General requirements
The parameters of the close-loop system which are exposed to the monitors are also specified. No activation conflict should happen within muscle tissue musclepaths=path automata 1-10 in Fig 3(b) ; State_musclepaths should never be Double 6 Figure 11 . General requirements for the close-loop system a p, v p, a s and v s are the pace and sense events of the pacemaker.
1) No Ventricular pace should happen during ventricle refractory (Priority 1):
This requirement is the most important safety requirement for implantable cardiac device. Pacing during the ventricle refractory period creates derangements in timing across the ventricle. This disturbs the normal coordinated contraction of the ventricle and can lead to unsafe ventricle fibrillation.
2) Each atrial and ventricular event should be sensed by the corresponding lead (Priority 2): Sensed intrinsic heart activation signals are essential inputs for the pacemaker. The pacemaker should ensure that the actual heart activations are accurately sensed and noise should be filtered.
3) Ventricular rate should be maintained between 60bpm and 120bpm (Priority 3): Ventricular rate determines the actual cardiac output. It is necessary for the pacemaker to keep the ventricular rate above a certain level to ensure the requisite cardiac output and below certain level to ensure efficient pumping.
4) Without an activity sensor the pacemaker should not increase the ventricular rate above its programmed LRI during Bradycardia and above the intrinsic heart rate during NSR (Priority 4):
In some cases, the pacemaker may try to pace the heart at inappropriate high rates (like the two PMT cases in Section IV). The pacemaker should always give intrinsic heart signal higher priority and increase the heart rate only when it's necessary.
5) If the intrinsic heart rate is below a certain threshold, after each atrial event there should be a ventricular event within a predefined interval (Priority 5):
A 1:1 A-V conduction should be maintained and coordinated to ensure efficient pumping. This is an efficacy requirements of the closed-loop system.
6) No activation conflict should happen within muscle tissue (Priority 6):
Activation conflicts within the muscle tissues disturbs the normal contraction pattern which might compromise the efficacy of cardiac output. Consequently, intrinsic and artificially paced signal should ensure coordinated contraction without conflicts across the muscle paths 1-10 (as shown in Fig. 3(b) ).
C. Conditional requirements
Besides the general requirements, additional conditional requirements are specified for specific patient condition Figure 12 . Conditional requirements for the close-loop system such as Normal Sinus Rhythm, Bradycardia, Heart Block, Supraventricular tachycardia and Endless Loop Tachycardia. These requirements are shown in Fig. 12 and cover common critical patient conditions.
VI. CLOSED-LOOP SYSTEM TESTING Currently there does not exist a unified approach for verification of Simulink models. Therefore, we use a testing procedure similar to Instrumentation Based Verification (IBV) [21] . In this procedure, monitors are designed and utilized to check for any violation of the closed-loop requirements. The proposed approach uses coverage-based testing and, thus, it can be used only in combination with tools for automatic test data generation. Several such commercial (e.g., Reactis, Design Verifier) and non-commercial (e.g., [22] , [23] ) tools exist. However, to test the case studies described in Section IV the closed-loop system input test vectors are created based on physiological requirements.
In this section, we describe design of the monitors used for testing of the requirements presented in Section V, a method used to generate input test cases, along with results obtained with these test vectors.
A. Monitor Designs
For each requirement described in Section V, a monitor is designed to generate an event when a violation of the property occurs. Using Assertion block in Simulink we are able to detect any violation of the imposed closed-loop system requirement and capture the execution scenario (i.e., simulation trace) which has led to the violation.
The monitors utilized for the closed-loop system testing are grouped into the following categories: M1. Monitors for logical conditions: When a requirement can be described using logical operations over system's signals, it is necessary to check whether at each time instance the predefined combination of signals and/or (VHM and pacemaker's) states might occur. For example, the first condition from Fig. 11 can be described as:
(State RV A == ERP ) ∧ (¬V pace ).
M2. Single event monitor:
A subset of the requirements can be described as a combination of timing dependencies between consecutive appearances of a single event. For example, the second requirement from the time duration between these two events has to be within a predefined bound. For example, consider Requirement 5 from Fig. 11 . It imposes a condition that the SA activation signal is always followed by the RVA activation signal. In addition, the RVA activation signal must not occur before 100ms have elapsed from the SA activation or later than 150ms after the SA activation signal (i.e., lower and upper bound). The monitor used to check for violations for this type of requirements is presented in Fig. 14 where the time interval is described as [T low , T high ].
M4. Combination monitors:
In general, a requirement can be described as a combination of the previously described requirements (from M1-3). In this case, the aforementioned monitors are composed to generate intermediate signals/events. However, it is necessary to modify the monitors presented in Fig. 13 and Fig. 14 . These 'modified' monitors have a similar structure as M1-M3 with a difference that they do not contain the F ail state and all transitions to the F ail state in the initial monitor designs are altered to become transitions to the Idle state. These modifications enable a continuous tracking of the intermediate properties that would not be possible if the monitor gets blocked in the F ail state, after the appropriate scenario occurs.
To illustrate this, consider a monitor in Fig. 15 used to check the fifth requirement from Fig. 11 . The monitor uses a 'modified' Single Event Monitor. In this case, by setting the monitor's parameters T low = 0s and T high = 0.6s, its output signal (i.e., T M SingleEvent.F ail) represents the condition that the heart rate is below the predefined threshold. In addition, a 'modified' monitor of type M3 with parameters T low = 0.1s and T high = 0.15s is used to check time durations between SA and RVA activation 
B. Generation of Test Vectors
To test the close-loop system we need to specify the inputs for the heart model to cover certain physiologically relevant heart conditions. We now specify inputs of the VHM for the four cases discussed in section IV. In our test approach, the inputs of the heart model are only those heart parameters that can be changed over time. This property significantly reduces the number of inputs and the model complexity.
1) Maintaining the heart rate: The heart rate is a function of the blood demand of the body and is controlled by the nervous system. The nervous system controls the heart rate by changing the firing rate of the SA node. Failure to increase the heart rate when needed leads to Bradycardia. In this base case, we model the heart rate variation of a patient with intermittent Bradycardia by altering the T rest timer value of the SA node automata. The range of T rest of the SA node automata is confined to [600, 1500]ms. It changes every 2 heart beats and the step is 10ms/beat. Using this scheme, we generate a 2-hour long test vector with T rest increase from 600ms to 1000ms and back to 600ms. This provides test coverage across a physiologically relevant parametric range.
2) Maintaining A-V synchrony: The nervous system controls the A-V conduction delay/block by changing the ERP timer of the AV node. Correspondingly, we mimic the behavior in VHM by changing the T ERP timer value of AV node automata.For simplicity, we only specify two distinct values for the T ERP timer value of AV node automata, which correspond to the state "AV-block" and "No AV block". In this case we run the simulation twice for the input given in case 1, one for "AV-block" and one for "No AV block".
3) Endless Loop Tachycardia (ELT):
In this case, we are interested in how Pacemaker Mediated Tachycardia can influence the requirements satisfaction. We use the same input in Case 2 for the SA and AV node automata, and introduce Premature Ventricle Contraction (PVC) to induce Endless Loop Tachycardia. In this case, we set the RV node automata to be active 200ms after the simulation begin.
4) Atrial flutter and pacemaker Mode-switch function:
In this case we are interested in checking if the pacemaker with Mode-switch function can switch from DDD mode to VDI mode during SVT and switch back after SVT terminates. For simplicity and clinical relevance, we induce the Atrial flutter by setting the fast pathway to refractory and activate the node automata at the circuit entry. This mimics the behavior when an early atrial signal successfully gets into the circuit at the right time and induce Atrial flutter. We terminate atrial flutter by disabling the slow pathway.
C. Results
1) Maintain heart rate and A-V synchrony:
We combined Case 1 and 2 together and ran the simulation with monitors. The results are shown in Fig. 16 . From the table we can see that during AV block, general Requirements 3 and 5 are violated and applying an AAI pacemaker will not help. In this situation, a DDD pacemaker can satisfy all the requirements so the therapy is appropriate for a patient with AV-block.
2) Endless Loop Tachycardia: The simulation results are shown in Fig. 17 . As can be noticed from the table, after the ELT is induced, varying the heart condition does not stop it and does not affect the outcome. In fact the pacemaker "Hijacked" the heart rate and puts the patient into a fixed and potentially unsafe condition.
3) Atrial flutter and pacemaker Mode-switch function: The result of the simulation is shown in Fig. 18 . We observe that during Atrial flutter, the close-loop system with a DDD VII. DISCUSSION
A. Future Work
As a part of our future efforts we plan to improve generation of the test vectors that would allow heart rate smoothening over a desired interval of time. In addition, it would be beneficial to consider a more complex pacemaker model which would include Rate Response modes (e.g., DDDR mode) specified in [9] , [10] . Finally, as an avenue of the future work we plan to investigate methods for the closed-loop system verification. With this approach our goal is to translate the VHM from Simulink into UPPAAL [24] , a widely used tool for system verification, where properties have to be expressed using temporal logic formulas before they are checked. Due to the limitations of the monitor based approach, UPPAAL presents a natural way to verify closedloop system using the timed automata framework.
B. Conclusion
There is currently no software testing standard for implantable medical devices such as pacemakers and cardioverter defibrillators. We present a method for testing of pacemakers within the closed-loop context of a heart model. A set of general and patient condition-specific temporal requirements is specified for the closed-loop system. Based on these requirements, we presented an interactive and physiologically relevant model-based test generation for basic and complex pacemaker operations. With the use of monitors, we demonstrate the proposed system is capable of testing common and complex heart conditions across pacemaker modes. This system is a step toward a testing approach for medical cyber-physical systems with the patient-in-the-loop.
